Covid-19 in Colombia: Epidemiology and What has Been Done
Once you register for the course, you will have 30 days from the date of enrollment to complete the course. The exact date that your access expires will be indicated within the Course Summary box on this webpage.
- Discuss the development of the pandemic and its effects in Colombia.
- Compare the effects of the pandemic between the US and Colombia.
Recording date: March 4, 2021
Date of original release: March 8, 2021
Most recent review/update: March 8, 2021
Termination date: March 7, 2024
María Luisa Latorre, PhD
Dr. Latorre is a Medical Doctor with a master’s degree in Health Administration with an emphasis in Social Wellfare and a PhD in Public Health from Universidad Nacional in Colombia. Her PhD thesis was about Sudden Infant Death Syndrome in Colombia.
She has worked at the Colombian Ministry of Health and Social Protection and the Health Secretary and Planning Departments in Bogotá. She was the first Director of Así Vamos en Salud, a health observatory and thinktank, for more than 5 years and has been consultant for the United Nations Millenium Development Goals. She is currently the Director of the Master’s in Public Health Program at Fundación Universitaria Juan N. Corpas.
Her research results have been published in books and national and international peer reviewed journals.
Juan Carlos Correa, MD, MPH
Dr. Correa has extensive experience in conducting public health research in Colombia and the US. He worked as an Associate Research Scientist at the Mailman School of Public Health at Columbia University for 6 years where he participated in research involving respiratory and cardiovascular effects of air pollution. He has also worked in Colombia at several institutions in the public and private sectors conducting public health interventions in communities throughout the country. Dr. Correa currently teaches in the Master’s in Public Health Program at Fundación Universitaria Juan N. Corpas.
His research has been published in national and international peer reviewed journals.
- MD: This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Iowa Medical Society (IMS). Des Moines University (DMU) is accredited by the IMS to provide continuing medical education for physicians. DMU designates this enduring materials activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
- DO: Des Moines University (DMU) is accredited by the American Osteopathic Association (AOA) to provide osteopathic continuing medical education for physicians. DMU designates this program for a maximum of 1.0 AOA Category 2-B credits and will report CME and specialty credits commensurate with the extent of the physician’s participation in this activity.
- Nurse: Des Moines University is Iowa Board of Nursing approved provider #112. This activity has been reviewed and approved for 1.0 continuing education contact hour(s). No partial credit awarded.
- Other Healthcare Professionals: This enduring materials activity is designated for a maximum of 1.0 AMA PRA Category 1 Credit(s)™.
No commercial interest company provided financial support for this continuing education activity.
The speaker(s) will disclose if any pharmaceuticals or medical procedures and devices discussed are investigational or unapproved for use by the U.S. Food and Drug Administration (FDA). Determination of educational content and the selection of speakers is the responsibility of the activity director.
Relevant to the content of this educational activity, the following individuals have no financial conflicts with commercial interest companies to disclose:
- María Luisa Latorre, PhD - Speaker
- Juan Carlos Correa, MD, MPH - Speaker
- Sondra Schreiber - Activity Director
The information provided at this activity is for continuing education purposes only and is not meant to substitute for the independent medical judgment of a healthcare provider relative to diagnostic and treatment options of a specific patient’s medical condition. The content of each presentation does not necessarily reflect the views of Des Moines University.
- 1.00 AMA PRA Category 1 Credits™
- 1.00 AOA Category 2B
- 1.00 CE Contact Hour(s)
- 1.00 IBON